Cipla
Search results
4 days ago · Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries. Subscribe on YouTube. Sun Pharma Story.
Sun Pharmaceutical Industries Limited (d/b/a Sun Pharma) is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe.
Sun Pharmaceutical Industries Ltd. (Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of US$ 5.4 billion. Supported by 43 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.
Sun Pharma has built a portfolio of patent protected speciality medicines for global markets. Over the years, we have nurtured this evolving business through increased focus and investments. The key segments we are targeting are dermatology, ophthalmology and oncology.
3 days ago · Sun Pharma EPS has increased to Rs. 11.10 in March 2024 from Rs. 8.30 in March 2023. Sun Pharma shares closed at 1,516.25 on June 27, 2024 (NSE) and has given 22.92% returns over the last 6 months ...
Get the latest Sun Pharmaceutical Industries Ltd (SUNPHARMA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and...
We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities...
Nov 1, 2023 · HYDERABAD, Nov 1 (Reuters) - Sun Pharmaceutical Industries (SUN.NS), India's largest drugmaker by revenue, reported a bigger-than-expected rise in second-quarter profit on Wednesday,...
Jan 23, 2023 · Questions have been raised about how Australia ensures the quality of its imported medicines is up to standard after a major pharmaceutical company was warned over lapses in contamination control ...
Jun 21, 2024 · Show more companies. BENGALURU, June 21 (Reuters) - Japan's Takeda Pharmaceutical (4502.T) gave India's Sun Pharmaceutical (SUN.NS) and Cipla (CIPL.NS) the rights to commercialize gastrointestinal ...
May 22, 2024 · Indian drugmaker Sun Pharmaceutical Industries posted fourth-quarter profit above estimates on Wednesday, helped by strong performance in its key U.S. and domestic markets.
Find the latest Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) stock quote, history, news and other vital information to help you with your stock trading and investing.
Sun Pharma Share Price: Find the latest news on Sun Pharma Stock Price. Get all the information on Sun Pharma with historic price charts for NSE / BSE.
Sun Pharmaceutical Industries Ltd (Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of US$ 5.4 billion. Supported by 43 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.
Jun 24, 2024 · Sun Pharma's high growth Global Specialty portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for over 18% of company sales.
Jun 24, 2024 · Sun Pharma Industries on Monday said it has completed the merger of Taro Pharmaceutical Industries with itself in a deal valued at $347.73 million. As part of the merger, Sun Pharma has ...
May 26, 2023 · Sun Pharmaceuticals announced its Q4FY23 results on May 26, reporting a consolidated net profit of ₹ 1,984 crore, compared to a net loss of ₹ 2,277 crore in the corresponding period last year.
Jun 21, 2024 · Sun Pharmaceutical Industries Ltd shares gained in morning trade on Friday after the company said it is entering a licensing agreement with Japan’s Takeda Pharma for marketing of a drug used for the treatment of gastrointestinal problems. In a stock exchange filing, Sun Pharma said it has signed a ...
Jul 7, 2023 · Cut to 2023. In FY23, Sun Pharma registered its highest-ever consolidated revenue of Rs 43,279 crore and net profit of Rs 8,474 crore, signalling to the market that the company was back in the...
Jan 31, 2024 · India's largest drugmaker Sun Pharmaceutical Industries reported third-quarter profit above estimates on Wednesday, driven by strong sales in the key domestic and U.S. markets.
Welcome to MySunPharma! Please login below with your username and password.
About Sun Pharma. Vision & Values. Milestones & Recognitions. Operations. Products. Innovation. Quality. Investors. Financials.
Jun 29, 2023 · With its headquarters in Mumbai, India, Sun Pharma is committed to developing and manufacturing a diverse range of pharmaceutical products, including generic drugs, branded drugs, and specialty products.
Sun Pharma is once again in the news, and once again for the wrong reasons. Recently, the pharmaceutical company received a warning letter from the United States Food and Drug Authority or USFDA.
Sun Pharmaceutical Industries Limited is an India-based specialty generic pharmaceutical company. The Company is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and active pharmaceutical ingredients (APIs).
